Arnica montana Gel in Osteoarthritis of the Knee: An Open, Multicenter Clinical Trial
Otto Knuesel, Michel Weber, Andy Suter
Advances In Therapy 2002
Abstract
This open multicenter trial investigated the safety and efficacy of an Arnica montana fresh plant gel, applied-twice daily, in 26 men and 53 warnen with mild to moderate osteoarthritis (OA) of the knee.
After 3 and 6 weeks, significant decreases in median total scores on the Western Ontario and McMaster Universities Osteoarthritis Index (WO MAC) were evident in the intention-to-treat and per-protocol populations (both P<.OOOl). Scores on the pain, stiffness, and function subscales also showed significant reductions at these timepoints. The overall local adverse-event rate of 7.6% includecl only one allergic reaction. Sixty-nine patients (87%) rated the tolerability of the gel as "good" or "fairly good," and 76% would use it again.
Topicall application of Arnica montana gel for 6 weeks was a safe, well-tolerated, and effective treatment of mild to moderate OA of the knee.